XORTX Therapeutics Inc.
XORTX Therapeutics Inc. is focused on developing drug therapies for metabolic and cardiovascular disease. The company has lead programs to develop treatments for progressive kidney disease due to diabetes - diabetic nephropathy- and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease.
XORTX Therapeutics Inc. (XRX)
Le 10 janvier/January 2018
XORTX Therapeutics Inc., the issuer resulting from a Fundamental Change of APAC Resources Inc. has been approved for listing.